Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

34 recalls, newest first

Class I · High risk

SILINTAN 25/pills

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

Ongoing Chemical / undeclared ANTHONY TRINH, 123Herbals LLC D-0388-2026
Class I · High risk

Mojo Max Fusion XXX

Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Ongoing Chemical / undeclared Mohamed Hagar D-0396-2026
Class II · Moderate risk

Afco

cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Ongoing Chemical / undeclared Acuity Specialty Products, Inc. D-0005-2026
Class II · Moderate risk

Wyandotte

cGMP deviations: The recall was initiated because required receipt testing of incoming alcohol components used to manufacture the listed hand sanitizers was not performed, so methanol risk could not be excluded.

Ongoing Chemical / undeclared Acuity Specialty Products, Inc. D-0004-2026
Class II · Moderate risk

edunn clarity

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0668-2025
Class II · Moderate risk

Micronized BPO Gel Cleanser 10%

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0667-2025
Class II · Moderate risk

mel rx Skin

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0666-2025
Class II · Moderate risk

Skin MD by Dr Monika Kiripolsky

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0664-2025
Class II · Moderate risk

Artisan of Skin

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide products.

Ongoing Chemical / undeclared Private Label Skin Care Inc. D-0663-2025
Class I · High risk

Umovy Acido Hialuronico

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Completed Chemical / undeclared Umary-USA.com D-0493-2025
Class I · High risk

Unavy Acido Hialuronico

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

Completed Chemical / undeclared Umary-USA.com D-0492-2025
Class I · High risk

Endurance Boost With Horny Goat Weed

Marketed without approved NDA/ANDA: The product has been found to be tainted with Sildenafil and Propoxyphenylsildenafil (a sildenafil analogue).

Ongoing Chemical / undeclared EnShiShiXiangNiShangMaoYouXianGongSi D-0453-2025
Class I · High risk

Male Ultra Pro

Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.

Ongoing Chemical / undeclared Saini Trade INC D-0467-2025
Class I · High risk

Ultra Armor

Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.

Ongoing Chemical / undeclared Saini Trade INC D-0466-2025
Class I · High risk

Electro Buzz

Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared chloropretadalafil, propoxyphenylsildenafil, and sildenafil.

Ongoing Chemical / undeclared Saini Trade INC D-0465-2025
Class I · High risk

Malextra

Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.

Ongoing Chemical / undeclared Saini Trade INC D-0464-2025
Class I · High risk

Male Ultra

Marketed without an Approved NDA/ANDA: Laboratory analysis found the product to be tainted with undeclared propoxyphenylsildenafil and sildenafil.

Ongoing Chemical / undeclared Saini Trade INC D-0463-2025

Recalls by year